Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis.

Goda K, Saito K, Muta K, Kobayashi A, Saito Y, Sugai S.

J Toxicol Sci. 2018;43(6):395-405. doi: 10.2131/jts.43.395.

2.

Cladosporamide A, a new protein tyrosine phosphatase 1B inhibitor, produced by an Indonesian marine sponge-derived Cladosporium sp.

Rotinsulu H, Yamazaki H, Sugai S, Iwakura N, Wewengkang DS, Sumilat DA, Namikoshi M.

J Nat Med. 2018 Jun;72(3):779-783. doi: 10.1007/s11418-018-1193-y. Epub 2018 Mar 5.

PMID:
29508256
3.

A pharmacologic increase in activity of plasma transaminase derived from small intestine in animals receiving an acyl CoA: diacylglycerol transferase (DGAT) 1 inhibitor.

Yokoyama H, Kobayashi A, Kondo K, Oshida SI, Takahashi T, Masuyama T, Shoda T, Sugai S.

J Toxicol Sci. 2018;43(2):135-157. doi: 10.2131/jts.43.135.

4.

High fructose diet feeding accelerates diabetic nephropathy in Spontaneously Diabetic Torii (SDT) rats.

Toyoda K, Suzuki Y, Muta K, Masuyama T, Kakimoto K, Kobayashi A, Shoda T, Sugai S.

J Toxicol Sci. 2018;43(1):45-58. doi: 10.2131/jts.43.45.

5.

A Design Principle for an Autonomous Post-translational Pattern Formation.

Sugai SS, Ode KL, Ueda HR.

Cell Rep. 2017 May 16;19(7):1494. doi: 10.1016/j.celrep.2017.05.017. No abstract available.

6.

A Design Principle for an Autonomous Post-translational Pattern Formation.

Sugai SS, Ode KL, Ueda HR.

Cell Rep. 2017 Apr 25;19(4):863-874. doi: 10.1016/j.celrep.2017.03.081. Erratum in: Cell Rep. 2017 May 16;19(7):1494.

7.

Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human-Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans.

Goda K, Kobayashi A, Takahashi A, Takahashi T, Saito K, Maekawa K, Saito Y, Sugai S.

Int J Mol Sci. 2017 Apr 12;18(4). pii: E810. doi: 10.3390/ijms18040810.

8.

Arachidonic acid-containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen-induced hepatic phospholipidosis.

Saito K, Goda K, Kobayashi A, Yamada N, Maekawa K, Saito Y, Sugai S.

J Appl Toxicol. 2017 Aug;37(8):943-953. doi: 10.1002/jat.3442. Epub 2017 Jan 31.

PMID:
28138993
9.

A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease.

Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, Miyashita T, Fujikawa K, Dobashi H, Susaki K, Morimoto H, Takagi K, Kawano M, Origuchi T, Wada Y, Takahashi N, Horikoshi M, Ogishima H, Suzuki Y, Kawanami T, Kawanami Iwao H, Sakai T, Fujita Y, Fukushima T, Saito M, Suzuki R, Morikawa Y, Yoshino T, Nakamura S, Kojima M, Kurose N, Sato Y, Tanaka Y, Sugai S, Sumida T.

Mod Rheumatol. 2017 Sep;27(5):849-854. doi: 10.1080/14397595.2016.1259602. Epub 2016 Dec 15.

PMID:
27846767
10.

Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.

Goda K, Takahashi T, Kobayashi A, Shoda T, Kuno H, Sugai S.

J Toxicol Sci. 2016;41(5):605-15. doi: 10.2131/jts.41.605.

11.

Isolation and structural determination of a new antibacterial compound demethyl-L-681,217 from Streptomyces cattleya.

Sugai S, Komaki H, Hemmi H, Kodani S.

J Antibiot (Tokyo). 2016 Nov;69(11):839-842. doi: 10.1038/ja.2016.53. Epub 2016 May 25. No abstract available.

PMID:
27220410
12.

BCR-ABL-specific CD4+ T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells.

Ueda N, Zhang R, Tatsumi M, Liu TY, Kitayama S, Yasui Y, Sugai S, Iwama T, Senju S, Okada S, Nakatsura T, Kuzushima K, Kiyoi H, Naoe T, Kaneko S, Uemura Y.

Cell Mol Immunol. 2018 Jan;15(1):15-26. doi: 10.1038/cmi.2016.7. Epub 2016 May 15.

13.

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.

Sugai S, Yoshikawa T, Iwama T, Tsuchiya N, Ueda N, Fujinami N, Shimomura M, Zhang R, Kaneko S, Uemura Y, Nakatsura T.

Int J Oncol. 2016 May;48(5):1794-804. doi: 10.3892/ijo.2016.3403. Epub 2016 Feb 19.

14.

Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model.

Fujinami N, Yoshikawa T, Sawada Y, Shimomura M, Iwama T, Sugai S, Kitano S, Uemura Y, Nakatsura T.

Biochem Biophys Rep. 2016 Feb 19;5:482-491. doi: 10.1016/j.bbrep.2016.02.010. eCollection 2016 Mar.

15.

Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice.

Iwama T, Uchida T, Sawada Y, Tsuchiya N, Sugai S, Fujinami N, Shimomura M, Yoshikawa T, Zhang R, Uemura Y, Nakatsura T.

Biochem Biophys Res Commun. 2016 Jan 1;469(1):138-143. doi: 10.1016/j.bbrc.2015.11.084. Epub 2015 Nov 23.

16.

Professor Norman Talal 1934-2015.

Moutsopoulos HM, Sugai S, Sawada S, Koike T, Miyasaka N, Kobayashi S, Takei M, Ogawa N.

Mod Rheumatol. 2015 Jul;25(4):664. doi: 10.3109/14397595.2015.1052683. No abstract available.

PMID:
26095110
18.

Superconducting pairing and the pseudogap in the nematic dynamical stripe phase of La2-xSrxCuO4.

Sugai S, Takayanagi Y, Hayamizu N, Muroi T, Shiozaki R, Nohara J, Takenaka K, Okazaki K.

J Phys Condens Matter. 2013 Nov 27;25(47):475701. doi: 10.1088/0953-8984/25/47/475701. Epub 2013 Oct 28.

PMID:
24166932
19.

Correlation between Raman sum and optical conductivity sum in La(2-x)Sr(x)CuO4.

Sugai S, Nohara J, Shiozaki R, Muroi T, Takayanagi Y, Hayamizu N, Takenaka K, Okazaki K.

J Phys Condens Matter. 2013 Oct 16;25(41):415701. doi: 10.1088/0953-8984/25/41/415701. Epub 2013 Sep 20.

PMID:
24055839
20.

Enhancement of acetaminophen-induced chronic hepatotoxicity in restricted fed rats: a nonclinical approach to acetaminophen-induced chronic hepatotoxicity in susceptible patients.

Kondo K, Yamada N, Suzuki Y, Toyoda K, Hashimoto T, Takahashi A, Kobayashi A, Shoda T, Kuno H, Sugai S.

J Toxicol Sci. 2012;37(5):911-29.

21.

Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease.

Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, Nakada S, Matsui S, Origuchi T, Nishiyama S, Yamada K, Kawano M, Hirabayashi A, Fujikawa K, Sugiura T, Horikoshi M, Umeda N, Minato H, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, Eguchi K, Sugai S, Umehara H.

Int J Rheumatol. 2012;2012:580814. doi: 10.1155/2012/580814. Epub 2012 May 10.

22.

American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort.

Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T; Sjögren's International Collaborative Clinical Alliance (SICCA) Research Groups.

Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87.

23.

p38 mitogen-activated protein kinase and nuclear factor-κB facilitate CD40-mediated salivary epithelial cell death.

Ping L, Ogawa N, Zhang Y, Sugai S, Masaki Y, Weiguo X.

J Rheumatol. 2012 Jun;39(6):1256-64. doi: 10.3899/jrheum.110097. Epub 2012 Apr 15.

PMID:
22505709
24.

Clinical impact of intraoperative detection of carcinoembryonic antigen mRNA in pleural lavage specimens from nonsmall cell lung cancer patients.

Satoh Y, Sugai S, Uehara H, Mun M, Sakao Y, Okumura S, Nakagawa K, Ishikawa Y, Miki Y, Miyata S.

Thorac Cardiovasc Surg. 2012 Dec;60(8):533-40. doi: 10.1055/s-0031-1298066. Epub 2012 Jan 17.

PMID:
22252332
25.

Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry.

Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, Banushree R, Dong Y, Helin P, Kirkham BW, Li M, Sugai S, Umehara H, Vivino FB, Vollenweider CF, Zhang W, Zhao Y, Greenspan JS, Daniels TE, Criswell LA.

Arthritis Care Res (Hoboken). 2012 Jun;64(6):911-8. doi: 10.1002/acr.21610. Epub 2012 Jan 11.

26.

Effects of spaced feeding on gene expression of hepatic transaminase and gluconeogenic enzymes in rats.

Kobayashi A, Yokoyama H, Kataoka J, Ishida T, Kuno H, Sugai S, Sakakibara H, Shimoi K.

J Toxicol Sci. 2011 Jun;36(3):325-37.

27.

Relationships between plasma and tissue transaminase activities in rats maintained under different feeding conditions.

Kobayashi A, Oshida S, Yamazaki Y, Maekawa T, Kuno H, Sugai S, Sakakibara H, Shimoi K.

J Toxicol Sci. 2010 Oct;35(5):639-52.

28.

Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis.

Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, Yamamoto M, Takahashi H, Matsui S, Nakada S, Origuchi T, Hirabayashi A, Homma N, Tsubata Y, Takata T, Wada Y, Saito A, Fukase S, Ishioka K, Miyazaki K, Masaki Y, Umehara H, Sugai S, Narita I.

Kidney Int. 2010 Nov;78(10):1016-23. doi: 10.1038/ki.2010.271. Epub 2010 Aug 18.

29.

Transconjunctival single-plane sclerocorneal incisions versus clear corneal incisions in cataract surgery.

Sugai S, Yoshitomi F, Oshika T.

J Cataract Refract Surg. 2010 Sep;36(9):1503-7. doi: 10.1016/j.jcrs.2010.03.045.

PMID:
20692562
30.

IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights.

Masaki Y, Sugai S, Umehara H.

J Rheumatol. 2010 Jul;37(7):1380-5. doi: 10.3899/jrheum.091153. Epub 2010 May 1. Review.

PMID:
20436071
31.

Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats.

Kobayashi A, Suzuki Y, Kuno H, Sugai S, Sakakibara H, Shimoi K.

J Toxicol Sci. 2009 Oct;34(4):377-87.

32.

An early view of the international Sjögren's syndrome registry.

Daniels TE, Criswell LA, Shiboski C, Shiboski S, Lanfranchi H, Dong Y, Schiødt M, Umehara H, Sugai S, Challacombe S, Greenspan JS; Sjögren's International Collaborative Clinical Alliance Research Groups.

Arthritis Rheum. 2009 May 15;61(5):711-4. doi: 10.1002/art.24397. No abstract available.

33.

Intravascular large B cell lymphoma: proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition.

Masaki Y, Dong L, Nakajima A, Iwao H, Miki M, Kurose N, Kinoshita E, Nojima T, Sawaki T, Kawanami T, Tanaka M, Shimoyama K, Kim C, Fukutoku M, Kawabata H, Fukushima T, Hirose Y, Takiguchi T, Konda S, Sugai S, Umehara H.

Int J Hematol. 2009 Jun;89(5):600-10. doi: 10.1007/s12185-009-0304-7. Epub 2009 Apr 14.

PMID:
19363707
34.

Controlled vaporization of the superconducting condensate in cuprate superconductors by femtosecond photoexcitation.

Kusar P, Kabanov VV, Demsar J, Mertelj T, Sugai S, Mihailovic D.

Phys Rev Lett. 2008 Nov 28;101(22):227001. Epub 2008 Nov 24.

PMID:
19113512
35.

Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial.

Sugai S, Takahashi H, Ohta S, Nishinarita M, Takei M, Sawada S, Yamaji K, Oka H, Umehara H, Koni I, Sugiyama E, Nishiyama S, Kawakami A.

Mod Rheumatol. 2009;19(2):114-24. doi: 10.1007/s10165-008-0141-1. Epub 2008 Dec 17.

PMID:
19089532
36.

Recurrence pattern and rapid intraoperative detection of carcinoembryonic antigen (CEA) mRNA in pleural lavage in patients with non-small cell lung cancer (NSCLC).

Sugai S, Satoh Y, Komatsu M, Okumura S, Nakagawa K, Ishikawa Y, Miki Y.

Rinsho Byori. 2008 Oct;56(10):851-7.

PMID:
19068780
37.

Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.

Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Saeki T, Azumi A, Nakada S, Sugiyama E, Matsui S, Origuchi T, Nishiyama S, Nishimori I, Nojima T, Yamada K, Kawano M, Zen Y, Kaneko M, Miyazaki K, Tsubota K, Eguchi K, Tomoda K, Sawaki T, Kawanami T, Tanaka M, Fukushima T, Sugai S, Umehara H.

Ann Rheum Dis. 2009 Aug;68(8):1310-5. doi: 10.1136/ard.2008.089169. Epub 2008 Aug 13.

PMID:
18701557
38.

Current and prospective treatment options for Sjögren's syndrome.

Sugai S, Masaki Y.

Expert Rev Clin Immunol. 2008 Jul;4(4):469-79. doi: 10.1586/1744666X.4.4.469.

PMID:
20477575
39.

Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells.

Fujikado N, Saijo S, Yonezawa T, Shimamori K, Ishii A, Sugai S, Kotaki H, Sudo K, Nose M, Iwakura Y.

Nat Med. 2008 Feb;14(2):176-80. doi: 10.1038/nm1697. Epub 2008 Jan 20.

PMID:
18204462
40.

Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial.

Nakayamada S, Saito K, Umehara H, Ogawa N, Sumida T, Ito S, Minota S, Nara H, Kondo H, Okada J, Mimori T, Yoshifuji H, Sano H, Hashimoto N, Sugai S, Tanaka Y.

Mod Rheumatol. 2007;17(6):464-9. Epub 2007 Dec 20.

PMID:
18084697
41.

Correlation-driven heavy-fermion formation in LiV2O4.

Jönsson PE, Takenaka K, Niitaka S, Sasagawa T, Sugai S, Takagi H.

Phys Rev Lett. 2007 Oct 19;99(16):167402. Epub 2007 Oct 19.

PMID:
17995290
42.

Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome.

Dong L, Masaki Y, Takegami T, Jin ZX, Huang CR, Fukushima T, Sawaki T, Kawanami T, Saeki T, Kitagawa K, Sugai S, Okazaki T, Hirose Y, Umehara H.

Clin Exp Immunol. 2007 Nov;150(2):279-84. Review.

43.

Sjögren's syndrome, glomerulonephritis and malignant lymphoma.

Sugai S.

Intern Med. 2007;46(4):155-6. Epub 2007 Feb 15. No abstract available.

44.

Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.

Dong L, Masaki Y, Takegami T, Kawanami T, Itoh K, Jin ZX, Huang CR, Tong XP, Fukushima T, Tanaka M, Sawaki T, Sakai T, Sugai S, Okazaki T, Hirose Y, Umehara H.

Int Immunol. 2007 Mar;19(3):331-6. Epub 2007 Jan 31.

PMID:
17272286
45.

Phason and amplitudon in the charge-density-wave phase of one-dimensional charge stripes in La(2-x)Sr(x)CuO4.

Sugai S, Takayanagi Y, Hayamizu N.

Phys Rev Lett. 2006 Apr 7;96(13):137003. Epub 2006 Apr 6.

PMID:
16712024
46.

Urinary pseudouridine in patients with lymphoma: comparison with other clinical parameters.

Masaki Y, Itoh K, Sawaki T, Karasawa H, Kawanami T, Fukushima T, Kawabata H, Wano Y, Hirose Y, Suzuki T, Sugai S, Umehara H.

Clin Chim Acta. 2006 Sep;371(1-2):148-51. Epub 2006 Apr 27.

PMID:
16643879
47.

[Marginal zone lymphoma associated with Sjögren's syndrome and hepatitis C virus infection].

Ebata K, Masaki Y, Karasawa H, Okada J, Kim CG, Tsuka M, Ogawa N, Wano Y, Hirose Y, Sugai S.

Nihon Rinsho Meneki Gakkai Kaishi. 2001 Aug;24(4):160-7. Japanese.

PMID:
16578967
48.

[Successful salvage therapy of continuous low-dose irinotecan for a patient with relapsed and refractory diffuse large B-cell lymphoma].

Masaki Y, Sawaki T, Shimoyama K, Karasawa H, Kawanami T, Fukushima T, Kawabata H, Ogawa N, Wano Y, Sugai S, Hirose Y, Umehara H.

Rinsho Ketsueki. 2005 Sep;46(9):1074-7. Japanese.

PMID:
16440768
49.

Collapse of coherent quasiparticle states in theta-(BEDT-TTF)2I3 observed by optical spectroscopy.

Takenaka K, Tamura M, Tajima N, Takagi H, Nohara J, Sugai S.

Phys Rev Lett. 2005 Nov 25;95(22):227801. Epub 2005 Nov 23.

PMID:
16384266
50.

Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome.

Huang M, Ida H, Kamachi M, Iwanaga N, Izumi Y, Tanaka F, Aratake K, Arima K, Tamai M, Hida A, Nakamura H, Origuchi T, Kawakami A, Ogawa N, Sugai S, Utz PJ, Eguchi K.

Clin Exp Immunol. 2005 Oct;142(1):148-54.

Supplemental Content

Support Center